Senior Lecturer in Pharmacy Practice, Course Leader (MSc Clinical Pharmacy).

My role is to develop teaching, scholarship and research related to pharmacy practice. I study safe and effective use of medicines. For full publications, see https://research.brighton.ac.uk/en/persons/ravina-barrett/publications/ or https://scholar.google.com/citations?hl=en&user=hGQ8ca0AAAAJ or ORCID profile.

Alternate Vice Chair of Research Ethics Committees (RECs) leading Clinical Trials review: I led the UK reviewer for the Ramdesivier trial which is the first drug licensed for use in the COVID-19 pandemic globally. I have been a NHS REC Member since Nov 2015 and have personally reviewed over 300+ studies including Clinical Trials of an Investigational Medicinal Product (CTIMP) or device as the chair, lead or second reviewer, within the studies reviewed by the committee.

• Recognised Key Opinion Leader with industry (collaboration with Ipsen pharma). My publications have attracted industry collaboration, leading to real world evidence research publications and conference presentation, bringing energy and innovation to old therapeutic areas. Abstract and poster are due to be presented at EMUC 2022 entitled “Medication adherence among patients with prostate cancer prescribed luteinizing hormone-releasing hormone agonists in England: Primary results from a real-world, retrospective cohort study" with IPSEN.
• Awareness of NHS decision-making and workflow processes (clinical trials pharmacist experience).
• Deep understanding of statistical and data analytics (see extensive Real World Evidence publication record) used to analyse prescription medication use/coverage nationally.
• Extensive Health Research Authority Ethics Committee (acting Alt-Chair) experience of providing favourable ethical opinions for large commercial trials. I help companies and research teams design scientifically and ethically robust work within industry and academia. Experience of working with the Medicines and Healthcare products Regulatory Agency (MHRA) in this capacity. Have reviewed regulatory documents from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA).
• Financial education and experience of managing budgets within community pharmacy and hospital teams e.g.,site set up and costings.

I supervise students across a range of pharmacy practice research interests, including MPharm, MRes, MSc and PhD.

I graduated with an MPharm (Hons) Pharmacy degree from the University of Portsmouth and completed my pre-registration at Southampton General Hospital, University Hospital Southampton NHS Foundation Trust (UHS). I completed MSc Finance at Grenoble Graduate School of Business within Grenoble Ecole de Management. After seven years of community pharmacy practice, I returned to secondary care as a Clinical Trial’s Pharmacist. I have been an academic part-time since 2010-11 and full-time since 2014-15. I have taught in the School of Pharmacy at the University of Portsmouth, University College London and University of Brighton and have been teaching at the Brighton and Sussex Medical School since 2018-19.

I have invested time in developing my educational record, which include the following formal courses in addition to my undergraduate and postgraduate qualifications, aside from the self-directed study in scholarship and continued professional development as part of my professional body registration requirements:
a) Big Data Epidemiology (11 - 15 January 2021);
b) Essential Medical Statistics (8 March to 7 May 2021);
c) Statistical Computing with R and Stata (26 April to 18 June 2021) - all short-course at the University of Oxford for academic credit (20 credits each) 2020-21.

The London School of Economics and Political Science: Modelling Cost-Effectiveness in Healthcare (11 May to 5 July 2022).

In my ‘outside the university’ role as a NHS research ethics expert committee member (for the last 7-years), I have reviewed UK-wide trials and provided my committee with technical advice to make a final judgement on the ethical approval of running the studies in the UK and what this means for the rights, safety, dignity and confidentiality of participants. I was the lead reviewer in the UK for the ramdesivier trial which is the first drug licensed for use in the COVID-19 pandemic globally. I have been a NHS Research Ethics Committee Member since Nov 2015 and have personally reviewed over 300+ studies, including Clinical Trials of an Investigational Medicinal Product (CTIMP) for drugs and device as the lead or second reviewer. In 2021, I was appointed as the Alternate Vice Chair for three years.

I'm open to knowledge exchange with public and private companies and other related activities.

I have been a pharmacist for 15 years within community and hospital pharmacy and a full-time academic since 2015. I teach pharmacy & therapeutics to medicine and pharmacy students. Much of my teaching is in Pharmacy Practice, on The Master of Pharmacy (MPharm) degree programme, Overseas (non-EEA) Pharmacists Assessment Programme (OSPAP) as well as MSc Clinical Pharmacy course that I lead. I also teach on the Bachelor of Medicine, Bachelor of Surgery (MBBS) course within Brighton and Sussex Medical School (BSMS).

I have taken and passed the UK registration exams (2005) and the Competency Assessment of Overseas Pharmacist (CAOP, Stream B) exam set by the Australian Pharmacy Council (2012). I am a UK registered pharmacist (GPHC: 2063234) with the General Pharmaceutical Council and engaged in Continuing Professional Development (CPD) since 2006. I am a Fellow of the Higher Education Academy (FHEA).

My intensive educational and personal experience helps me understand the student perspective (both domestic and foreign) and journey through university life with respect to Pharmacy.

I teach in ways that promotes active connections between the fundamental sciences and impact on patient care. I use technology in my teaching to aid blended learning, real-time capture and interactive teaching. 

I exclusively engage students in research that has real world impact and is likely to lead to publications.